Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRKG1 Antikörper (AA 1-300)

PRKG1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7147509
  • Target Alle PRKG1 Antikörper anzeigen
    PRKG1 (Protein Kinase, CGMP-Dependent, Type I (PRKG1))
    Bindungsspezifität
    • 9
    • 8
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 1-300
    Reaktivität
    • 42
    • 27
    • 13
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 36
    • 6
    Kaninchen
    Klonalität
    • 38
    • 4
    Polyklonal
    Konjugat
    • 24
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PRKG1 Antikörper ist unkonjugiert
    Applikation
    • 35
    • 23
    • 16
    • 7
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human cGMP-dependent protein kinase 1 protein (1-300AA)
    Isotyp
    IgG
    Top Product
    Discover our top product PRKG1 Primärantikörper
  • Applikationshinweise
    Recommended dilution: WB:1:500-1:2000,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    PRKG1 (Protein Kinase, CGMP-Dependent, Type I (PRKG1))
    Andere Bezeichnung
    PRKG1 (PRKG1 Produkte)
    Synonyme
    prkg1 antikoerper, zgc:63955 antikoerper, Pkgi antikoerper, cGk1 antikoerper, 1 antikoerper, PKG antikoerper, PRKG1B antikoerper, PRKGR1B antikoerper, cGK antikoerper, cGK 1 antikoerper, cGK1 antikoerper, cGKI antikoerper, cGKI-BETA antikoerper, cGKI-alpha antikoerper, CGKI antikoerper, cGKI-beta antikoerper, AW125416 antikoerper, Gm19690 antikoerper, Prkg1b antikoerper, Prkgr1b antikoerper, Prkg1beta antikoerper, protein kinase, cGMP-dependent, type Ia antikoerper, protein kinase, cGMP-dependent, type I antikoerper, protein kinase, cGMP-dependent, type 1 antikoerper, prkg1a antikoerper, PRKG1 antikoerper, prkg1 antikoerper, Prkg1 antikoerper
    Hintergrund

    Background: Serine/threonine protein kinase that acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca2+ release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca2+ levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation, decreasing contraction, controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle.

    Aliases: cGK 1 antibody, cGK1 antibody, cGKI alpha antibody, cGKI antibody, cGKI beta antibody, cGMP-dependent protein kinase 1 antibody, cGMP-dependent protein kinase I antibody, DKFZp686K042 antibody, FLJ36117 antibody, KGP1_HUMAN antibody, KGPB antibody, MGC71944 antibody, pkg antibody, PRKG1 antibody, PRKG1B antibody, PRKGR1A antibody, PRKGR1B antibody

    UniProt
    Q13976
Sie sind hier: